5/17/2016

Amino Acid Products

Reason for the Shortage

- Baxter was experiencing increased demand.
- BBraun was experiencing increased demand.
- Hospira had amino acid products on back order due to manufacturing delays.

Available Products

- Aminosyn (sulfite-free) injection, Pfizer, 10%, 1000 mL flexible container, 6 count, NDC 00409-4191-05
- Aminosyn (sulfite-free) injection, Pfizer, 10%, 500 mL flexible container, 12 count, NDC 00409-4191-03
- Aminosyn (sulfite-free) injection, Pfizer, 3.5%, 1000 mL flexible container, 6 count, NDC 00409-4196-05
- Aminosyn (sulfite-free) injection, Pfizer, 8.5%, 500 mL flexible container, 12 count, NDC 00409-4187-03
- Aminosyn (sulfite-free) injection, Pfizer, 8.5% with electrolytes, 500 mL flexible container, 12 count, NDC 00409-4203-03
- Aminosyn II (sulfite-free) injection, Pfizer, 10%, 1000 mL flexible container, 6 count, NDC 00409-4164-05
- Aminosyn II (sulfite-free) injection, Pfizer, 10%, 2000 mL flexible container, 6 count, NDC 00409-7172-17
- Aminosyn II (sulfite-free) injection, Pfizer, 10%, 500 mL flexible container, 12 count, NDC 00409-4164-03
- Aminosyn II (sulfite-free) injection, Pfizer, 15%, 2000 mL flexible container, 6 count, NDC 00409-7171-17
- Aminosyn II (sulfite-free) injection, Pfizer, 8.5%, 500 mL flexible container, 12 count, NDC 00409-4162-03
- Aminosyn II (sulfite-free) injection, Pfizer, 8.5% with electrolytes, 500 mL flexible container, 12 count, NDC 00409-4171-03
- Aminosyn-PF (sulfite-free) injection, Pfizer, 10%, 1000 mL flexible container, 6 count, NDC 00409-4179-05
- Aminosyn-PF (sulfite-free) injection, Pfizer, 7%, 500 mL flexible container, 12 count, NDC 00409-4178-03
- Clinisol (sulfite-free) injection, Baxter, 15%, 2000 mL flexible container, 6 count, NDC 00338-0502-06
- Clinisol (sulfite-free) injection, Baxter, 15%, 500 mL flexible container, 24 count, NDC 00338-0502-03
- FreAmine III injection, BBraun, 10%, 1000 mL glass container, 6 count, NDC 00264-9010-55
- Plenamine injection, BBraun, 15%, 1000 mL glass container, 6 count, NDC 00264-3200-55
- Premasol (sulfite-free) injection, Baxter, 10%, 1000 mL flexible container, 12 count, NDC 00338-1130-04
- Premasol (sulfite-free) injection, Baxter, 10%, 2000 mL flexible container, 6 count, NDC 00338-1130-06
- Premasol (sulfite-free) injection, Baxter, 10%, 500 mL flexible container, 24 count, NDC 00338-1130-03
- Premasol (sulfite-free) injection, Baxter, 6%, 500 mL flexible container, 24 count, NDC 00338-1131-03
- Prosol (sulfite-free) injection, Baxter, 20%, 2000 mL flexible container, 6 count, NDC 00338-0499-06
- Travasol injection, Baxter, 10%, 1000 mL flexible container, 12 count, NDC 00338-0644-04
- Travasol injection, Baxter, 10%, 2000 mL flexible container, 6 count, NDC 00338-0644-03
- Travasol injection, Baxter, 10%, 2000 mL flexible container, NDC 00338-0644-06
- TrophAmine injection, BBraun, 10%, 500 mL glass container, 6 count, NDC 00264-9341-55
- TrophAmine injection, BBraun, 6%, 500 mL glass container, 12 count, NDC 00264-9361-55
- Aminosyn HBC (sulfite-free) injection, Pfizer, 7%, 500 mL flexible container, 12 count, NDC 00409-4168-03
- Aminosyn-RF (sulfite-free) injection, Pfizer, 5.2%, 500 mL flexible container, 12 count, NDC 00409-4166-03
- FreAmine HBC injection, BBraun, 6.9%, 750 mL glass container, 6 count, NDC 00264-9350-55
- HepatAmine, BBraun, 8%, 500 mL glass container, 6 count, NDC 00264-9371-55
- NephrAmine injection, BBraun, 5.4%, 250 mL glass container, 6 count, NDC 00264-1909-55
- ProcalAmine injection, BBraun, 1000 mL glass container, 6 count, NDC 00264-1915-07

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated May 17, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 4, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.